Senate Majority Leader John Thune (R-S.D.) told reporters Wednesday that he plans to keep the Senate in session through the weekend if Democrats don’t reverse course and help advance a House-passed ...

Minister of Trade, Industry and Competition Parks Tau said his department will monitor and investigate if Chinese online store Temu is complying with South African laws by operating a warehouse in the ...

Trade, Industry and Competition Minister Parks Tau remains optimistic about the renewal of the African Growth and Opportunity Act (Agoa) following a recent visit to Washington, DC and New York. In a ...

The GLP-1 agonist at the center of Pfizer’s upfront $4.9 billion buyout of Metsera last week has been tied to 14.1% weight loss at 28 weeks as well as “potentially class-leading tolerability,” ...

This widely used tauopathy model was developed at the University of Pennsylvania School of Medicine by Virginia Lee, John Trojanowski, and colleagues. As first reported in 2007 on a mixed background, ...

Watch: Gisèle Pelicot applauded and thanked as she arrived in court France's mass rape victim, Gisèle Pelicot, is returning to court on Monday to face one of her attackers, the only man who is ...

Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...

Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, ...

The United States-Africa preferential trade pact, known as the African Growth and Opportunity Act (AGOA), has officially expired. However, Trade, Industry and Competition Minister Parks Tau remains ...

The corporate headquarters of Allete, the parent company of the utility Minnesota Power, pictured here in Duluth on Sept. 3.

Find the latest Thesis Gold Inc. (TAU.V) stock quote, history, news and other vital information to help you with your stock trading and investing.

A subsidiary of Genmab will initiate a tender offer to acquire 100% of the common shares of Merus. Credit: ArDanMe/Shutterstock.com. Genmab has signed an agreement to buy all shares of clinical-stage ...